Onderneming Annexin Pharmaceuticals AB (publ) Nasdaq Stockholm
Aandelen
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Anna Frostegård
FOU | Founder | 51 | 01-01-14 |
Chief Executive Officer | 63 | 01-01-18 | |
Director of Finance/CFO | 53 | 11-04-23 | |
Susan Suchdev
COO | Chief Operating Officer | 52 | - |
Alain Thibault
PRN | Corporate Officer/Principal | - | 18-01-23 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Uli Alf Hacksell
CHM | Chairman | 74 | 01-01-21 |
Mårten Österlund
BRD | Director/Board Member | 67 | 01-01-21 |
Chief Executive Officer | 63 | 01-01-18 | |
Director/Board Member | 48 | 01-01-17 | |
Director/Board Member | 65 | 01-01-16 | |
Director/Board Member | 66 | 01-01-17 | |
Director/Board Member | 71 | - | |
Anthon Jahreskog
BRD | Director/Board Member | 44 | 01-01-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 526 807 199 | 256 124 467 ( 48,62 %) | 0 | 48,62 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,91% | 118 mld. | |
+11,60% | 106 mld. | |
-4,68% | 24,28 mld. | |
-0,82% | 21,96 mld. | |
-10,12% | 18,16 mld. | |
-42,12% | 16,37 mld. | |
-17,47% | 15,56 mld. | |
+2,77% | 13,63 mld. | |
+34,58% | 12,27 mld. |